Upgrade to SI Premium - Free Trial

EU panel backs Enhertu plus pertuzumab for HER2+ breast cancer

July 24, 2026 7:00 AM
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA